Trial intelligence / Profile preview

Retaane in Age-Related Macular Degeneration

NCT00569569Phase 3Completed

Sponsor
Klinik Landstraße
Start
Feb 2006
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of anecortave in age-related macular degeneration (AMD), sponsored by Klinik Landstraße. Started Feb 2006; status: completed.

02

Drugs

anecortave
03

Conditions

age-related macular degeneration (AMD)

Beyond the preview

Go deeper on NCT00569569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00569569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call